Related Experiment Videos
Modeling empiric antibiotic therapy evaluation of QID
H Warner1, L Reimer, D Suvinier
1First Consulting Group, University of Utah Medical Center, Salt Lake City, USA.
Proceedings. AMIA Symposium
|November 24, 1999
Summary
This study evaluated QID, a computer-based tool for empiric antibiotic decision support. QID significantly improved physicians' antibiotic choices, especially for complex cases.
Area of Science:
- Medical Informatics
- Clinical Decision Support Systems
- Infectious Diseases
Background:
- Empiric antibiotic selection is critical for patient outcomes before pathogen identification.
- Physician decision-making in antibiotic therapy can be complex and variable.
- Computer-based decision support tools aim to optimize antibiotic prescribing.
Purpose of the Study:
- To evaluate the impact of the QID (Questionable Infectious Disease) tool on empiric antibiotic decision-making.
- To assess whether QID improves the appropriateness of antibiotic regimens chosen by physicians.
- To determine if QID is more beneficial in complex infectious disease cases.
Main Methods:
- A "before and after" study design was employed.
- Internal medicine residents and attendings evaluated four abstracted infectious disease cases.
- Physicians' initial antibiotic choices were compared to choices made after reviewing QID recommendations.
Main Results:
- QID statistically improved overall empiric antibiotic choice scores (p < .001).
- The tool demonstrated a greater impact on more complex infectious disease cases.
- Physician adherence to QID recommendations varied, but overall appropriateness of therapy increased.
Conclusions:
- The QID tool enhances the appropriateness of empiric antibiotic selection in clinical practice.
- Decision support systems like QID are valuable for managing infectious diseases.
- Further integration of such tools can optimize patient care and antibiotic stewardship.